1. Home
  2. BRTX vs DEVS Comparison

BRTX vs DEVS Comparison

Compare BRTX & DEVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRTX
  • DEVS
  • Stock Information
  • Founded
  • BRTX 1997
  • DEVS N/A
  • Country
  • BRTX United States
  • DEVS Canada
  • Employees
  • BRTX N/A
  • DEVS N/A
  • Industry
  • BRTX Managed Health Care
  • DEVS
  • Sector
  • BRTX Health Care
  • DEVS
  • Exchange
  • BRTX Nasdaq
  • DEVS NYSE
  • Market Cap
  • BRTX 15.9M
  • DEVS 16.5M
  • IPO Year
  • BRTX N/A
  • DEVS N/A
  • Fundamental
  • Price
  • BRTX $1.80
  • DEVS $0.43
  • Analyst Decision
  • BRTX Strong Buy
  • DEVS
  • Analyst Count
  • BRTX 1
  • DEVS 0
  • Target Price
  • BRTX $18.00
  • DEVS N/A
  • AVG Volume (30 Days)
  • BRTX 812.7K
  • DEVS 224.7K
  • Earning Date
  • BRTX 03-28-2025
  • DEVS 03-04-2025
  • Dividend Yield
  • BRTX N/A
  • DEVS N/A
  • EPS Growth
  • BRTX N/A
  • DEVS N/A
  • EPS
  • BRTX N/A
  • DEVS N/A
  • Revenue
  • BRTX $377,000.00
  • DEVS N/A
  • Revenue This Year
  • BRTX $482.76
  • DEVS N/A
  • Revenue Next Year
  • BRTX $212.24
  • DEVS N/A
  • P/E Ratio
  • BRTX N/A
  • DEVS N/A
  • Revenue Growth
  • BRTX 189.55
  • DEVS N/A
  • 52 Week Low
  • BRTX $1.03
  • DEVS $0.41
  • 52 Week High
  • BRTX $2.55
  • DEVS $1.91
  • Technical
  • Relative Strength Index (RSI)
  • BRTX 37.55
  • DEVS N/A
  • Support Level
  • BRTX $2.26
  • DEVS N/A
  • Resistance Level
  • BRTX $2.38
  • DEVS N/A
  • Average True Range (ATR)
  • BRTX 0.22
  • DEVS 0.00
  • MACD
  • BRTX -0.09
  • DEVS 0.00
  • Stochastic Oscillator
  • BRTX 7.98
  • DEVS 0.00

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

About DEVS DEVVSTREAM CORP

DevvStream Corp is a technology based ESG company that advances the development and monetization of environmental assets, with an initial focus on carbon markets. It works with governments and corporations to achieve their sustainability goals through the implementation of curated green technology projects that generate renewable energy, improve energy efficiencies, eliminate or reduce emissions, and sequester carbon directly from the air.

Share on Social Networks: